Cardiac nonmyocytes in the hub of cardiac hypertrophy

Takehiro Kamo1, Hiroshi Akazawa1, Issei Komuro1

  • 1From the Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan (T.K., H.A., I.K.); and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Chiyoda-ku, Tokyo, Japan (H.A., I.K.).

Circulation Research
|June 20, 2015
PubMed

Insights

Nonmyocytes, crucial heart cells, actively drive cardiac hypertrophy through cell-to-cell communication. Understanding these interactions is key to developing new treatments for this condition.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Cardiac Pathophysiology

Background:

  • Cardiac hypertrophy involves complex multicellular changes including cardiomyocyte growth, angiogenesis, fibrosis, and inflammation.
  • The heart comprises myocytes and nonmyocytes (fibroblasts, vascular cells, blood cells) that communicate via autocrine/paracrine mediators.
  • Nonmyocytes are increasingly recognized for their active role in cardiac hypertrophy development.

Purpose of the Study:

  • To review recent advancements in understanding the role of nonmyocytes in cardiac hypertrophy.
  • To highlight the significance of nonmyocytes as a central hub for initiating cardiac hypertrophy.
  • To emphasize noncontact communication via diffusible factors between cardiomyocytes and nonmyocytes.

Main Methods:

  • Literature review of recent research on cardiac hypertrophy and nonmyocyte function.
  • Analysis of studies focusing on intercellular communication in the heart.
  • Synthesis of findings on diffusible factors mediating cardiomyocyte-nonmyocyte interactions.

Main Results:

  • Nonmyocytes play a critical role in the induction and progression of cardiac hypertrophy.
  • Noncontact communication, mediated by diffusible factors, is a significant mechanism in this process.
  • Understanding these cellular crosstalks provides insights into the multicellular nature of cardiac hypertrophy.

Conclusions:

  • Nonmyocytes are pivotal in cardiac hypertrophy, acting as a hub for disease induction.
  • Intercellular communication, particularly noncontact signaling, is fundamental to cardiac hypertrophy.
  • Further research into nonmyocyte-cardiomyocyte interactions may reveal novel therapeutic targets.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
749
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
20.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
5.4K